T1	PROC 49 73	estudio de investigación
#1	AnnotatorNotes T1	C0681814; research study; Research Activity
T2	CHEM 92 102	tipifarnib
#2	AnnotatorNotes T2	C1176289; tipifarnib; Organic Chemical · Pharmacologic Substance
T3	PROC 130 141	tratamiento
#3	AnnotatorNotes T3	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T4	DISO 148 155	linfoma
#4	AnnotatorNotes T4	C0024299; Lymphoma; Neoplastic Process
T5	PROC 172 184	tratamientos
#5	AnnotatorNotes T5	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T6	PROC 230 253	Estudio fase II abierto
T7	CHEM 257 267	Tipifarnib
#6	AnnotatorNotes T7	C1176289; tipifarnib; Organic Chemical · Pharmacologic Substance
T8	DISO 310 341	linfoma de células T periférico
#7	AnnotatorNotes T8	C0079774; Peripheral T-Cell Lymphoma; Neoplastic Process
T9	PROC 392 404	tratamientos
#8	AnnotatorNotes T9	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T10	ANAT 504 513	células T
#9	AnnotatorNotes T10	C0039194; T-Lymphocyte; Cell
T11	PROC 571 582	diagnóstico
#10	AnnotatorNotes T11	C0011900; Diagnosis; Diagnostic Procedure
T12	DISO 586 617	linfoma de células T periférico
#11	AnnotatorNotes T12	C0079774; Peripheral T-Cell Lymphoma; Neoplastic Process
T13	DISO 1040 1075	Linfoma Hepatosplénico de células T
#12	AnnotatorNotes T13	C1333984; Hepatosplenic T-cell lymphoma; Neoplastic Process
T14	DISO 716 762	tumores de tejidos linfoides o hematopoyéticos
T15	ANAT 727 744	tejidos linfoides
#13	AnnotatorNotes T15	C0024296; Lymphoid Tissue; Tissue | C1284825; Entire lymphocytic tissue; Tissue
T16	DISO 791 828	Linfoma anaplásico de células grandes
#14	AnnotatorNotes T16	C0206180; Ki-1+ Anaplastic Large Cell Lymphoma; Neoplastic Process
T17	DISO 918 922	AITL
T18	DISO 830 834	LACG
#15	AnnotatorNotes T18	C0206180; Ki-1+ Anaplastic Large Cell Lymphoma; Neoplastic Process
T19	DISO 854 858	LACG
#16	AnnotatorNotes T19	C0206180; Ki-1+ Anaplastic Large Cell Lymphoma; Neoplastic Process
T20	DISO 876 916	Linfoma angioinmunoblástico de células T
#17	AnnotatorNotes T20	C0020981; Angioimmunoblastic Lymphadenopathy; Neoplastic Process
T21	DISO 927 970	Linfoma de células T asociado a enteropatía
#18	AnnotatorNotes T21	C0456889; Enteropathy-Associated T-Cell Lymphoma; Neoplastic Process
T22	DISO 974 1035	Linfoma extranodal de células T y de células (NK), tipo nasal
#19	AnnotatorNotes T22	C0392788; Nasal Type Extranodal NK/T-Cell Lymphoma; Neoplastic Process
T23	ANAT 996 1005	células T
#20	AnnotatorNotes T23	C0039194; T-Lymphocyte; Cell
T24	ANAT 1011 1018	células
#21	AnnotatorNotes T24	C0007634; Cells; Cell | C1269647; Entire cell; Cell
T25	ANAT 1020 1022	NK
#22	AnnotatorNotes T25	C0022688; Natural Killer Cells; Cell
T26	ANAT 1030 1035	nasal
#23	AnnotatorNotes T26	C0028429; Nose; Body Part, Organ, or Organ Component
T27	ANAT 1066 1075	células T
#24	AnnotatorNotes T27	C0039194; T-Lymphocyte; Cell
T28	DISO 1081 1112	Linfoma periférico de células T
#25	AnnotatorNotes T28	C0079774; Peripheral T-Cell Lymphoma; Neoplastic Process
T29	ANAT 1103 1112	células T
#26	AnnotatorNotes T29	C0039194; T-Lymphocyte; Cell
T30	DISO 1149 1207	Linfoma de apariencia paniculítica subcutáneo de células T
#27	AnnotatorNotes T30	C0522624; Subcutaneous panniculitis-like T-cell lymphoma; Neoplastic Process
T31	ANAT 1198 1207	células T
#28	AnnotatorNotes T31	C0039194; T-Lymphocyte; Cell
T32	PROC 1236 1247	Diagnóstico
#29	AnnotatorNotes T32	C0011900; Diagnosis; Diagnostic Procedure
T33	DISO 1281 1314	Precursor de linfoma de células T
#30	AnnotatorNotes T33	C1292758; Precursor T-cell lymphoblastic lymphoma; Neoplastic Process
T34	DISO 1317 1325	leucemia
#31	AnnotatorNotes T34	C0023418; leukemia; Neoplastic Process
T35	DISO 1329 1369	Linfoma/Leucemia de células T del adulto
#32	AnnotatorNotes T35	C0023493; Adult T-Cell Lymphoma/Leukemia; Neoplastic Process
T36	ANAT 1349 1358	células T
#33	AnnotatorNotes T36	C0039194; T-Lymphocyte; Cell
T37	DISO 1373 1409	Leucemia prolinfocítica de células T
#34	AnnotatorNotes T37	C2363142; T-Cell Prolymphocytic Leukemia; Neoplastic Process
T38	ANAT 1400 1409	células T
#35	AnnotatorNotes T38	C0039194; T-Lymphocyte; Cell
T39	DISO 1413 1463	Leucemia linfocítica granular de células T grandes
#36	AnnotatorNotes T39	C2930809; Neutropenia and hyperlymphocytosis with large granular lymphocytes; Disease or Syndrome
T40	DISO 1467 1518	Limfoma anaplásico de células grandes, tipo cutáneo
T41	ANAT 1489 1504	células grandes
#37	AnnotatorNotes T41	C1513997; Neoplastic Large Cell; Cell (?)
T42	ANAT 1511 1518	cutáneo
#38	AnnotatorNotes T42	C0011646; Dermis; Tissue | C1123023; Skin; Body System
T43	DISO 1522 1538	Micosis fungoide
#39	AnnotatorNotes T43	C0026948; Mycosis Fungoides; Neoplastic Process
T44	DISO 1540 1555	Síndrome Sézary
#40	AnnotatorNotes T44	C0036920; Sezary Syndrome; Neoplastic Process
T45	ANAT 321 330	células T
#41	AnnotatorNotes T45	C0039194; T-Lymphocyte; Cell
T46	ANAT 597 606	células T
#42	AnnotatorNotes T46	C0039194; T-Lymphocyte; Cell
T47	ANAT 813 828	células grandes
T48	ANAT 907 916	células T
#43	AnnotatorNotes T48	C0039194; T-Lymphocyte; Cell
T49	ANAT 938 947	células T
#44	AnnotatorNotes T49	C0039194; T-Lymphocyte; Cell
T50	ANAT 1305 1314	células T
#45	AnnotatorNotes T50	C0039194; T-Lymphocyte; Cell
T51	ANAT 1422 1433	linfocítica
#46	AnnotatorNotes T51	C0024264; Lymphocyte; Cell
T52	ANAT 1446 1463	células T grandes
T53	DISO 365 372	Limfoma
T54	DISO 493 524	limfoma de células T periférico
T55	DISO 619 623	PTCL
T56	Date 13 17	2016
T58	LIVB 271 280	pacientes
#47	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T59	LIVB 456 463	Sujetos
#48	AnnotatorNotes T59	C0681850; Study Subject; Group
T60	LIVB 555 561	sujeto
#49	AnnotatorNotes T60	C0681850; Study Subject; Group
T61	Date 655 663	reciente
T62	PHYS 747 762	hematopoyéticos
#50	AnnotatorNotes T62	C0018951; Hematopoiesis; Organ or Tissue Function
T63	Neg_cue 864 872	negativo
T66	LIVB 1363 1369	adulto
#51	AnnotatorNotes T66	C0001675; Adult; Age Group
T57	GENE 860 863	ALK
#52	AnnotatorNotes T57	C1332080; ALK gene; Gene or Genome
T67	GENE 837 840	ALK
#53	AnnotatorNotes T67	C1332080; ALK gene; Gene or Genome
T64	DISO 285 292	recaída
#54	AnnotatorNotes T64	C0699753; Cancer Relapse; Neoplastic Process
T65	DISO 468 475	recaída
#55	AnnotatorNotes T65	C0699753; Cancer Relapse; Neoplastic Process
A1	Assertion T57 Negated
A2	Population_data T66 Age
A3	Status T5 History_of
A4	Status T9 History_of
#56	AnnotatorNotes T6	C0282460; Phase 2 Clinical Trials; Research Activity + C1709323; Open Label Study; Research Activity 
#57	AnnotatorNotes T53	C0024299; Lymphoma; Neoplastic Process
#58	AnnotatorNotes T54	C0079774; Peripheral T-Cell Lymphoma; Neoplastic Process
#59	AnnotatorNotes T55	C0079774; Peripheral T-Cell Lymphoma; Neoplastic Process
#60	AnnotatorNotes T17	C0020981; Angioimmunoblastic Lymphadenopathy; Neoplastic Process
#61	AnnotatorNotes T61	C0332185; Recent; Temporal Concept
T68	Quantifier_or_Qualifier 1118 1145	alguna otra caracterización
A5	Assertion T68 Negated
T69	Neg_cue 1114 1117	sin
R1	Used_for Arg1:T2 Arg2:T3	
R4	Experiences Arg1:T58 Arg2:T7	
R5	Experiences Arg1:T58 Arg2:T64	
R6	Location_of Arg1:T45 Arg2:T8	
R7	Before Arg1:T8 Arg2:T64	
T70	Observation 295 307	refractarios
#62	AnnotatorNotes T70	C0438286; Absent response to treatment; Finding
R8	Experiences Arg1:T58 Arg2:T70	
R9	Before Arg1:T8 Arg2:T70	
T71	Observation 172 206	tratamientos previos han fracasado
#63	AnnotatorNotes T71	C0438286; Absent response to treatment; Finding
R10	Before Arg1:T4 Arg2:T2	
T72	Observation 392 429	tratamientos anteriores hayan fallado
#64	AnnotatorNotes T72	C0438286; Absent response to treatment; Finding
R11	Before Arg1:T53 Arg2:T72	
T73	Observation 478 490	refractarias
#65	AnnotatorNotes T73	C0438286; Absent response to treatment; Finding
R12	Experiences Arg1:T59 Arg2:T73	
R13	Experiences Arg1:T59 Arg2:T65	
R14	Location_of Arg1:T10 Arg2:T54	
R15	Experiences Arg1:T59 Arg2:T54	
R16	Before Arg1:T54 Arg2:T73	
R17	Before Arg1:T54 Arg2:T65	
R18	Experiences Arg1:T60 Arg2:T12	
R19	Location_of Arg1:T46 Arg2:T12	
R20	Location_of Arg1:T46 Arg2:T55	
R21	Experiences Arg1:T60 Arg2:T14	
R22	Location_of Arg1:T15 Arg2:T14	
R24	Location_of Arg1:T47 Arg2:T16	
R25	Location_of Arg1:T47 Arg2:T18	
R26	Negation Arg1:T63 Arg2:T57	
T74	Result_or_Value 841 849	positivo
#66	AnnotatorNotes T74	C1446409; Positive; Finding
R27	Has_Result_or_Value Arg1:T67 Arg2:T74	
R28	Overlap Arg1:T16 Arg2:T67	
R29	Overlap Arg1:T19 Arg2:T57	
R30	Overlap Arg1:T18 Arg2:T67	
#67	AnnotatorNotes T47	C1513997; Neoplastic Large Cell; Cell (?)
R31	Location_of Arg1:T48 Arg2:T20	
R32	Location_of Arg1:T48 Arg2:T17	
R33	Location_of Arg1:T49 Arg2:T21	
R34	Location_of Arg1:T23 Arg2:T22	
R37	Location_of Arg1:T27 Arg2:T13	
R38	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T28	
T75	ANAT 1048 1062	Hepatosplénico
#68	AnnotatorNotes T75	C0545797; liver and spleen; Body Location or Region
R39	Location_of Arg1:T75 Arg2:T13	
R40	Negation Arg1:T69 Arg2:T68	
R41	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T68	
R42	Location_of Arg1:T31 Arg2:T30	
R43	Location_of Arg1:T50 Arg2:T33	
R44	Location_of Arg1:T36 Arg2:T35	
R45	Experiences Arg1:T66 Arg2:T35	
R46	Location_of Arg1:T38 Arg2:T37	
R47	Location_of Arg1:T51 Arg2:T39	
#69	AnnotatorNotes T52	C1513997; Neoplastic Large Cell; Cell (?)
R48	Location_of Arg1:T52 Arg2:T39	
R49	Location_of Arg1:T41 Arg2:T40	
R50	Location_of Arg1:T26 Arg2:T22	
R51	Location_of Arg1:T42 Arg2:T40	
T76	Spec_cue 89 91	si
R52	Speculation Arg1:T76 Arg2:T2	
A6	Assertion T2 Speculated
T77	Quantifier_or_Qualifier 106 112	seguro
A7	Assertion T77 Speculated
R53	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T77	
R54	Speculation Arg1:T76 Arg2:T77	
T78	Quantifier_or_Qualifier 115 121	eficaz
A8	Assertion T78 Speculated
#70	AnnotatorNotes T78	C1704419; Effective; Qualitative Concept
R55	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T78	
R56	Speculation Arg1:T76 Arg2:T78	
R57	Before Arg1:T5 Arg2:T71	
R3	Before Arg1:T71 Arg2:T2	
R2	Before Arg1:T71 Arg2:T3	
R58	Experiences Arg1:T58 Arg2:T8	
R59	Before Arg1:T9 Arg2:T72	
R60	Experiences Arg1:T60 Arg2:T62	
R23	Location_of Arg1:T25 Arg2:T22	
#71	AnnotatorNotes T40	C1301362; Primary Cutaneous Anaplastic Large Cell Lymphoma; Neoplastic Process
#72	AnnotatorNotes T14	C5681309; Tumor of hematopoietic and lymphoid tissues; Neoplastic Process (?)
A9	Experiencer T58 Patient
A10	Experiencer T59 Patient
A11	Experiencer T60 Patient
A12	Experiencer T66 Patient
A13	Status T72 History_of
A14	Status T71 History_of
T79	Result_or_Value 864 872	negativo
R35	Has_Result_or_Value Arg1:T57 Arg2:T79	
